Page last updated: 2024-08-17

ethinyl estradiol and Obesity

ethinyl estradiol has been researched along with Obesity in 71 studies

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-199016 (22.54)18.7374
1990's2 (2.82)18.2507
2000's18 (25.35)29.6817
2010's32 (45.07)24.3611
2020's3 (4.23)2.80

Authors

AuthorsStudies
Chaturvedula, A; Cicali, B; Cristofoletti, R; Hoechel, J; Lingineni, K; Schmidt, S; Vozmediano, V; Wendl, T; Wiesinger, H1
Hu, H; Li, F; Li, W; Liu, J; Ma, Z; Zou, G1
Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O1
Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L2
Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO1
Adler, TE; Stachenfeld, NS; Takamata, A; Usselman, CW1
Edelman, AB; Jusko, WJ; Luo, D; Natavio, M; Stanczyk, FZ; Westhoff, CL1
Bender, JR; Leone, CA; Stachenfeld, NS; Steele, FE; Taylor, HS; Usselman, CW; Yarovinsky, TO1
Conway, GS; Lee, MC1
Mayeda, ER; Torgal, AH; Westhoff, CL1
Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Rubin, A; Westhoff, CL1
Bangerter, K; Merz, M; Reinecke, I; Westhoff, CL1
Cherala, G; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ1
Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR1
Chen, A; Du, J; Du, Y; Liao, YC; Lin, XF; Wang, Y; Wu, C; Wu, RR; Ye, Y; Zhang, XB1
Archer, DF; Nakajima, ST; Pappadakis, J1
Ellakwa, H; Gamal, A; Rezk, M; Sayyed, T; Zahran, A1
Jusko, WJ1
Cao, Y; Jiang, Y; Wu, J; Zhu, Y1
del Rey Sánchez, JM; Escobar-Morreale, HF; Luque-Ramírez, M; Matíes, M; Mendieta-Azcona, C1
Cameron, JL; Carlson, NE; Cherala, G; Edelman, AB; Jensen, JT; Munar, MY; Stanczyk, FZ; Stouffer, RL1
Cleuren, AC; Hoylaerts, MF; Lijnen, HR; van Hoef, B; van Vlijmen, BJ1
Chen, HF; Chen, MJ; Chen, SU; Ho, HN; Kuo, JJ; Yang, WS; Yang, YS1
Edelman, A; Patel, S; Stanczyk, FZ; Steiner, AZ1
Weisberg, E1
Mayeda, ER; Pike, MC; Stanczyk, FZ; Torgal, AH; Westhoff, CL1
Benn, EKT; Lerner, JP; Mayeda, ER; Paik, M; Stanczyk, FZ; Torgal, AH; Westhoff, CL1
Cherala, G; Edelman, AB; Stanczyk, FZ1
Bulechowsky, M; Cameron, J; Edelman, A; Jensen, JT1
Cheang, KI; Essah, PA; Nestler, JE; Sharma, S; Wickham, EP1
Adawadkar, SS; Arrowood, JA; Cheang, KI; Essah, PA; Nestler, JE; Stovall, DW1
Beasley, A; Estes, C; Guerrero, J; Westhoff, C1
Mayeda, ER; Pike, MC; Shimoni, N; Stanczyk, FZ; Torgal, AT; Westhoff, CL1
Cherala, G; Edelman, A; Elman, MR; Koop, D; Munar, M1
Cremers, S; Dragoman, M; Mayeda, ER; Petrie, K; Thomas, T; Torgal, AH; Westhoff, CL1
Archer, DF; Foegh, M; Mishell, DR; Rubin, A; Stanczyk, FZ1
Cherala, G; Dubois, B; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ1
Cremers, S; Dragoman, M; Petrie, K; Thomas, T; Torgal, A; Westhoff, CL1
Wemeau-jacquemont, C1
Bussen, SS; Dietl, J; Rieger, L; Steck, T; Sütterlin, MW1
Bialer, M; Doose, DR; Jacobs, D; Padmanabhan, M; Schwabe, S; Wang, SS1
Dahlgren, E; Holm, G; Janson, PO; Krotkiewski, M; Landin, K1
DEMOWBRAY, RR1
Hedberg, P; Morin-Papunen, L; Puukka, M; Rautio, K; Ruokonen, A; Tapanainen, JS1
Harma, M; Kilic, F; Nazligul, Y; Sabuncu, T1
De Zegher, F; Ibáñez, L1
Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS1
Déchêne, F; Dodin, S; Forest, JC; Lemay, A; Turcot, L1
Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R1
Atlas, M; Gordon, L; Januchowski, R; Thakur, N1
Demirci, F; Gul, OB; Ozdemir, I; Somunkiran, A; Yucel, O1
Grewal, S; Iroh Tam, PY; Richardson, M1
Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG1
Evans, E; Massoudi, M; Miller, DS1
Gallasch, E; Klöpping, K; Neumeyer, H; Seidel, D; Wieland, H1
Rubio Lotvin, B1
Arner, P; Bergqvist, A; Carlström, K; Ek, I; Reynisdottir, S; Wahrenberg, H1
Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS; Vauhkonen, I1
Lauritzen, C1
Brion, JP; Copinschi, G; De Laet, MH; Delvoye, P; Golstein, J; L'Hermite, M; Leclercq, R; Robyn, C; Van Cauter, E; Vanhaelst, L; Vekemans, M; Virasoro, E1
Hommel, G; Muck, BR1
Friedlander, DH; Snell, AP1
Mauvais-Jarvis, P; Plouin, PF1
Dunn, FG; Fife, R; Jones, JV1
Fotherby, K1
Stokes, T; Wynn, V1
Hancock, KW; Levell, MJ1
Diddle, AW; Semmer, JR1
Brohult, J; Westgren, A1
Boshell, BR; Fox, OJ; McAdams, GL; Roddam, RF1

Reviews

6 review(s) available for ethinyl estradiol and Obesity

ArticleYear
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
    PloS one, 2021, Volume: 16, Issue:7

    Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio

2021
Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.
    Contraception, 2019, Volume: 99, Issue:4

    Topics: Clinical Studies as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Humans; Levonorgestrel; Obesity

2019
Liver dysfunction in Turner syndrome and its relationship to exogenous oestrogen.
    European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:10

    Topics: Bile Duct Diseases; Biopsy; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Liver; Liver Diseases; Obesity; Turner Syndrome

2013
Clarification of contraceptive drug pharmacokinetics in obesity.
    Contraception, 2017, Volume: 95, Issue:1

    Topics: Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity

2017
Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review.
    Contraception, 2010, Volume: 82, Issue:4

    Topics: Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Intestinal Absorption; Obesity; Progestins; Skin Absorption; Steroids

2010
Oral contraceptives, lipids and cardiovascular disease.
    Contraception, 1985, Volume: 31, Issue:4

    Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Hyperthyroidism; Lipids; Norpregnenes; Obesity; Physical Exertion; Risk; Smoking

1985

Trials

34 trial(s) available for ethinyl estradiol and Obesity

ArticleYear
Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.
    Medicine, 2021, May-28, Volume: 100, Issue:21

    Topics: Administration, Oral; Adolescent; Adult; China; Cholesterol; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Isoflavones; Metformin; Obesity; Polycystic Ovary Syndrome; Primary Ovarian Insufficiency; Sex Hormone-Binding Globulin; Superoxide Dismutase; Tablets; Testosterone; Treatment Outcome; Young Adult

2021
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
    Archives of gynecology and obstetrics, 2018, Volume: 297, Issue:6

    Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome

2018
Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
    The Journal of physiology, 2019, Volume: 597, Issue:11

    Topics: Adult; Androgens; Cardiovascular Diseases; Dihydrotestosterone; Endothelin-1; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Microvessels; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Receptor, Endothelin B; Skin; Vascular Endothelial Growth Factor A; Vasodilation; Young Adult

2019
Weight and body composition changes during oral contraceptive use in obese and normal weight women.
    Journal of women's health (2002), 2014, Volume: 23, Issue:1

    Topics: Adult; Body Composition; Body Mass Index; Contraceptives, Oral; Dose-Response Relationship, Drug; Electric Impedance; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Obesity; Outcome Assessment, Health Care; Prospective Studies; Time Factors; Weight Gain; Weight Loss; Young Adult

2014
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
    Obstetrics and gynecology, 2014, Volume: 123, Issue:2 Pt 1

    Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Obesity; Patient Compliance; Pregnancy; Transdermal Patch; Treatment Outcome; Uterine Hemorrhage; Young Adult

2014
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
    Contraception, 2014, Volume: 90, Issue:3

    Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicular Phase; Follow-Up Studies; Humans; Lost to Follow-Up; Norpregnenes; Obesity; Oogenesis; Ovarian Follicle; Overweight; Ovulation Inhibition; Progesterone; Sex Hormone-Binding Globulin; Transdermal Patch; Ultrasonography; Young Adult

2014
Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.
    Contraception, 2014, Volume: 90, Issue:5

    Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Prospective Studies; Young Adult

2014
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
    American journal of obstetrics and gynecology, 2015, Volume: 212, Issue:3

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Obesity; Patient Outcome Assessment; Transdermal Patch; Young Adult

2015
Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive.
    Contraception, 2016, Volume: 93, Issue:1

    Topics: Adolescent; Adult; Amenorrhea; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Obesity; Pregnancy; Pregnancy, Unplanned; Young Adult

2016
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008, Volume: 24, Issue:7

    Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Waist-Hip Ratio

2008
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
    European journal of endocrinology, 2009, Volume: 160, Issue:3

    Topics: Adult; Androgen Antagonists; Blood Coagulation; Blood Platelets; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Fibrinogen; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Obesity; Partial Thromboplastin Time; Polycystic Ovary Syndrome; Prothrombin; Smoking; Young Adult

2009
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.
    Contraception, 2010, Volume: 81, Issue:6

    Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Menstrual Cycle; Obesity; Organ Size; Ovarian Follicle; Ovulation Inhibition; Progesterone; Radioimmunoassay; Ultrasonography; Young Adult

2010
Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial.
    Obstetrics and gynecology, 2010, Volume: 116, Issue:2 Pt 1

    Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Ovary; Prospective Studies; Young Adult

2010
Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women.
    Fertility and sterility, 2011, Volume: 96, Issue:2

    Topics: Academic Medical Centers; Adult; Analysis of Variance; Blood Glucose; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipoproteins, LDL; Norgestrel; Obesity; Prospective Studies; Thinness; Time Factors; Virginia; Young Adult

2011
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
    Fertility and sterility, 2011, Volume: 96, Issue:2

    Topics: Analysis of Variance; Biomarkers; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Norgestrel; Obesity; Overweight; Placebo Effect; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Vasodilation; Virginia

2011
The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.
    Contraception, 2012, Volume: 85, Issue:5

    Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Medication Adherence; Obesity; Patient Dropouts; Triglycerides; Young Adult

2012
Predictors of noncompliance in an oral contraceptive clinical trial.
    Contraception, 2012, Volume: 85, Issue:5

    Topics: Adolescent; Adult; Biomarkers; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Educational Status; Ethinyl Estradiol; Female; Hispanic or Latino; Humans; Levonorgestrel; Medication Adherence; Obesity; Ovarian Follicle; Ovulation Inhibition; Patient Dropouts; Poverty; Single-Blind Method; United States; Young Adult

2012
Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women.
    British journal of clinical pharmacology, 2012, Volume: 74, Issue:3

    Topics: Adolescent; Adult; Chromatography, Liquid; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Midazolam; Obesity; Prospective Studies; Tandem Mass Spectrometry; Young Adult

2012
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.
    American journal of obstetrics and gynecology, 2012, Volume: 207, Issue:1

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Endometrium; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstruation; Obesity; Ovarian Follicle; Prospective Studies; Young Adult

2012
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel.
    Contraception, 2013, Volume: 87, Issue:2

    Topics: Administration, Cutaneous; Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Middle Aged; Obesity; Ovary; Ovulation; Progesterone; Sex Hormone-Binding Globulin

2013
Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.
    Contraception, 2013, Volume: 87, Issue:4

    Topics: Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Obesity; Ovarian Follicle; Prospective Studies; Vagina; Young Adult

2013
Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects.
    Epilepsia, 2003, Volume: 44, Issue:4

    Topics: Administration, Oral; Adult; Anticonvulsants; Area Under Curve; Body Mass Index; Carbamazepine; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Enzyme Induction; Ethinyl Estradiol; Female; Fructose; Humans; Mestranol; Metabolic Clearance Rate; Norethindrone; Obesity; Topiramate

2003
Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:10

    Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Progesterone Congeners

2003
Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome.
    Fertility and sterility, 2003, Volume: 80, Issue:5

    Topics: Adult; Androgen Antagonists; Appetite Depressants; Blood Pressure; Body Constitution; Body Weight; Cyclobutanes; Cyproterone Acetate; Diastole; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Obesity; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides

2003
Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
    Human reproduction (Oxford, England), 2004, Volume: 19, Issue:8

    Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hypoglycemic Agents; Metformin; Norpregnenes; Obesity; Polycystic Ovary Syndrome

2004
Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
    European journal of endocrinology, 2005, Volume: 152, Issue:2

    Topics: Adult; Androgen Antagonists; Cardiovascular Diseases; Cholesterol; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Treatment Outcome

2005
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
    Human reproduction (Oxford, England), 2006, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Androgens; Blood Glucose; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones

2006
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
    Diabetes care, 2007, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome

2007
The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
    Archives of gynecology and obstetrics, 2008, Volume: 277, Issue:1

    Topics: Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicular Phase; Homocysteine; Humans; Lipids; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone

2008
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
    Human reproduction (Oxford, England), 2008, Volume: 23, Issue:7

    Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metformin; Obesity; Polycystic Ovary Syndrome; Risk Factors; Uric Acid

2008
Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:6

    Topics: Adipocytes; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Diet, Reducing; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Lipolysis; Norethindrone; Obesity; Polycystic Ovary Syndrome; Radioligand Assay; Sympathetic Nervous System; Weight Loss

1999
Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:9

    Topics: Adult; Androgen Antagonists; Area Under Curve; Blood Glucose; Calorimetry; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Fats; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome

2000
Oral contraceptive medication and glucose metabolism: long-term treatment.
    Southern medical journal, 1974, Volume: 67, Issue:6

    Topics: Adult; Blood Glucose; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Diabetes Mellitus; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Middle Aged; Norethindrone; Obesity; Pregnancy; Triglycerides

1974
Liver reaction in connection with oral contraceptive steroids.
    Acta obstetricia et gynecologica Scandinavica, 1969, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Alkaline Phosphatase; Amenorrhea; Bilirubin; Carbohydrate Metabolism; Clinical Trials as Topic; Contraceptives, Oral; Ethinyl Estradiol; Female; Hemorrhage; Humans; Jaundice; L-Lactate Dehydrogenase; Lipid Metabolism; Liver; Lynestrenol; Mestranol; Middle Aged; Nausea; Norethynodrel; Obesity; Ornithine Carbamoyltransferase; Proteins; Pruritus; Thrombophlebitis

1969

Other Studies

31 other study(ies) available for ethinyl estradiol and Obesity

ArticleYear
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
    CPT: pharmacometrics & systems pharmacology, 2021, Volume: 10, Issue:1

    Topics: Adult; Alkynes; Benzoxazines; Body Mass Index; Carbamazepine; Clarithromycin; Computer Simulation; Contraceptives, Oral, Combined; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Itraconazole; Levonorgestrel; Models, Biological; Obesity; Rifampin; Sex Hormone-Binding Globulin

2021
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:5

    Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult

2018
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
    Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:6

    Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides

2018
Blood pressure predicts endothelial function and the effects of ethinyl estradiol exposure in young women.
    American journal of physiology. Heart and circulatory physiology, 2018, 10-01, Volume: 315, Issue:4

    Topics: Adiposity; Administration, Oral; Adolescent; Adult; Antihypertensive Agents; Arterial Pressure; Brachial Artery; Drug Administration Schedule; Endothelium, Vascular; Ethinyl Estradiol; Exercise Test; Female; Hand Strength; Humans; Hypertension; Ischemia; Obesity; Time Factors; Treatment Outcome; Vasodilator Agents; Young Adult

2018
Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
    Clinical and experimental obstetrics & gynecology, 2015, Volume: 42, Issue:3

    Topics: Abortion, Spontaneous; Adult; Androgen Antagonists; Blood Glucose; Body Mass Index; Clomiphene; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Live Birth; Luteinizing Hormone; Metformin; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult

2015
Metabolic changes in overweight and obese women above 35 years using Ethinylestradiol/drosperinone combined contraceptive pills: a 3-year case-control study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:10

    Topics: Adult; Androstenes; Case-Control Studies; Ethinyl Estradiol; Female; Humans; Obesity; Overweight; Prospective Studies; Reproductive Control Agents

2016
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity.
    Contraception, 2009, Volume: 80, Issue:2

    Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Levonorgestrel; Luteinizing Hormone; Obesity; Young Adult

2009
Short-term ethinyl estradiol treatment suppresses inferior caval vein thrombosis in obese mice.
    Thrombosis and haemostasis, 2009, Volume: 102, Issue:5

    Topics: Adipose Tissue; Animals; Blood Coagulation Factors; Dietary Fats; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Inflammation; Interleukin-6; Lipids; Liver; Mice; Mice, Inbred C57BL; Models, Biological; Obesity; Organ Size; Ovariectomy; Serum Amyloid A Protein; Species Specificity; Thrombophilia; Uterus; Vena Cava, Inferior; Venous Thrombosis

2009
Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
    Human reproduction (Oxford, England), 2010, Volume: 25, Issue:3

    Topics: Adult; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Follistatin; Humans; Obesity; Polycystic Ovary Syndrome; Prospective Studies

2010
Antimullerian hormone and obesity: insights in oral contraceptive users.
    Contraception, 2010, Volume: 81, Issue:3

    Topics: Adolescent; Adult; Anti-Mullerian Hormone; Body Mass Index; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Levonorgestrel; Luteinizing Hormone; Obesity; Regression Analysis

2010
Contraceptive options for women in selected circumstances.
    Best practice & research. Clinical obstetrics & gynaecology, 2010, Volume: 24, Issue:5

    Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult

2010
Combined oral contraceptives and body weight: do oral contraceptives cause weight gain? A primate model.
    Human reproduction (Oxford, England), 2011, Volume: 26, Issue:2

    Topics: Animals; Basal Metabolism; Body Composition; Body Weight; Contraceptives, Oral, Combined; Energy Intake; Ethinyl Estradiol; Female; Levonorgestrel; Macaca mulatta; Obesity

2011
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.
    Contraception, 2013, Volume: 87, Issue:2

    Topics: Adolescent; Adult; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Progesterone; Prospective Studies

2013
[Choosing contraception for adolescents].
    NPN medecine, 1985, Feb-02, Volume: 5, Issue:84

    Topics: Adolescent; Age Factors; Behavior; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Disease; Estrogens; Ethinyl Estradiol; Europe; Family Planning Services; France; Hormones; Intrauterine Devices; Obesity; Population; Population Characteristics; Sexual Behavior; Spermatocidal Agents

1985
Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol.
    European journal of obstetrics, gynecology, and reproductive biology, 2003, Mar-26, Volume: 107, Issue:1

    Topics: Adolescent; Adult; Contraceptives, Oral; Diet, Vegetarian; Ethinyl Estradiol; Female; Folic Acid; Humans; Obesity; Smoking; Vitamin B 12; Vitamin B 12 Deficiency

2003
Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS.
    Gynecologic and obstetric investigation, 2003, Volume: 55, Issue:2

    Topics: Adipose Tissue; Adult; Androgen Antagonists; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Body Weight; C-Peptide; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Resistance; Leptin; Lipoprotein(a); Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides

2003
THE HORMONES AND PUBERTY.
    The Practitioner, 1964, Volume: 192

    Topics: Adolescent; Child; Chorionic Gonadotropin; Cryptorchidism; Diethylstilbestrol; Ethinyl Estradiol; Eunuchism; Female; Genital Neoplasms, Female; Gonadotropins; Humans; Hypogonadism; Hypothalamus; Klinefelter Syndrome; Male; Menstruation; Methyltestosterone; Obesity; Physiology; Puberty; Puberty, Precocious; Sexual Maturation; Surgical Procedures, Operative; Testosterone; Thyroid Gland; Thyroxine

1964
Clinical inquiries. What hormonal contraception is most effective for obese women?
    The Journal of family practice, 2007, Volume: 56, Issue:6

    Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Norgestrel; Obesity; Pregnancy; Pregnancy Rate; Risk Assessment

2007
Fatal case of bilateral internal jugular vein thrombosis following IVIg infusion in an adolescent girl treated for ITP.
    American journal of hematology, 2008, Volume: 83, Issue:4

    Topics: Adolescent; Anemia, Iron-Deficiency; Anticoagulants; Brain Edema; Combined Modality Therapy; Dexamethasone; Ethinyl Estradiol; Fatal Outcome; Female; Heparin; Humans; Immunoglobulins, Intravenous; Infusions, Intravenous; Jugular Veins; Mannitol; Metrorrhagia; Norethindrone; Obesity; Purpura, Thrombocytopenic, Idiopathic; Thrombectomy; Thrombolytic Therapy; Venous Thrombosis

2008
Thermogenic drugs for the treatment of obesity: screening using obese rats and mice.
    Annals of nutrition & metabolism, 1983, Volume: 27, Issue:1

    Topics: Animals; Body Weight; Eating; Ephedrine; Ethinyl Estradiol; Male; Mice; Mice, Inbred CBA; Obesity; Oxygen Consumption; Rats; Triiodothyronine

1983
[The influence of oral contraceptives on lipoprotein status (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1982, Apr-30, Volume: 107, Issue:17

    Topics: Adolescent; Adult; Blood Donors; Contraceptives, Oral; Cyproterone; Estrogens; Ethinyl Estradiol; Female; Humans; Lipoproteins; Lipoproteins, LDL; Mestranol; Obesity; Progesterone Congeners; Smoking

1982
[The desogestrel-ethinyl estradiol combination and overweight: current data].
    Ginecologia y obstetricia de Mexico, 1995, Volume: 63

    Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Obesity; Progesterone Congeners; Time Factors

1995
[Hormonal regulation and hormone therapy in childhood and adolescence. Part 2: Therapeutic problems (tall stature, amenorrhea, delayed puberty, oligomenorrhea, precocious puberty, anorexia nervosa, anisomastia, hypermastia, acne etc)].
    Fortschritte der Medizin, 1979, May-17, Volume: 97, Issue:19

    Topics: Acne Vulgaris; Adolescent; Amenorrhea; Anorexia Nervosa; Breast Diseases; Child; Cyproterone; Drug Combinations; Endocrine System Diseases; Estradiol Congeners; Ethinyl Estradiol; Female; Growth Disorders; Hirsutism; Humans; Menstruation Disturbances; Obesity; Oligomenorrhea; Progesterone Congeners; Puberty, Precocious

1979
[Hypophyseal hormonal rhythm in a physiological state].
    Problemes actuels d'endocrinologie et de nutrition, 1975, Volume: 19

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Cushing Syndrome; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Melanocyte-Stimulating Hormones; Middle Aged; Norgestrel; Obesity; Pituitary Hormones, Anterior; Pregnancy; Prolactin; Thyrotropin

1975
[Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use (author's transl)].
    Archiv fur Gynakologie, 1976, Volume: 221, Issue:1

    Topics: Adult; Age Factors; Blood Glucose; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Diabetes Mellitus; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lynestrenol; Mathematics; Megestrol; Mestranol; Middle Aged; Norethindrone; Norgestrel; Obesity; Time Factors

1976
Acute coronary artery disease and oral contraceptives.
    Australian and New Zealand journal of medicine, 1975, Volume: 5, Issue:1

    Topics: Acute Disease; Adult; Contraceptives, Oral; Coronary Disease; Ethinyl Estradiol; Female; Humans; Hypercholesterolemia; Myocardial Infarction; Obesity; Pregnancy; Pregnancy Complications, Cardiovascular; Smoking

1975
[Disorders of carbohydrate metabolism induced by steroid contraceptive agents].
    La Nouvelle presse medicale, 1975, Feb-01, Volume: 4, Issue:5

    Topics: Carbohydrate Metabolism; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Diabetes Mellitus; Ethinyl Estradiol; Female; Growth Hormone; Humans; Insulin; Insulin Secretion; Mestranol; Obesity; Progestins; Secretory Rate; Time Factors; Tryptophan; Vitamin B 6 Deficiency

1975
Malignant hypertension associated with use of oral contraceptives.
    British heart journal, 1975, Volume: 37, Issue:3

    Topics: Adult; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypertension, Malignant; Norethindrone; Obesity

1975
Serum-lipids in women on oral contraceptives.
    Lancet (London, England), 1971, Sep-25, Volume: 2, Issue:7726

    Topics: Age Factors; Body Weight; Cholesterol; Contraceptives, Oral; Coronary Disease; Estrogens; Ethinyl Estradiol; Fasting; Female; Humans; Hyperlipidemias; Lipids; Mestranol; Obesity; Parity; Progestins; Pulmonary Embolism; Thrombophlebitis; Time Factors; Triglycerides

1971
The use of oestrogen-progestogen preparations in the treatment of hirsutism in the female.
    The Journal of obstetrics and gynaecology of the British Commonwealth, 1974, Volume: 81, Issue:10

    Topics: 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Amenorrhea; Dexamethasone; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Hirsutism; Humans; Mestranol; Obesity; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone

1974
The effects of oral contraceptives on glucose tolerance.
    Journal of reproduction and fertility. Supplement, 1968, Volume: 5

    Topics: Administration, Oral; Adult; Blood Glucose; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Menopause; Mestranol; Middle Aged; Norgestrel; Obesity; Ovulation; Time Factors

1968